Insulin-Like growth factor-i receptor blockade improves outcome in mouse model of lung injury

Jung Eun Choi, Sung Soon Lee, Donald A. Sunde, Isham Huizar, Kathy L. Haugk, Victor J. Thannickal, Ragini Vittal, Stephen R. Plymate, Lynn M. Schnapp

Research output: Contribution to journalArticlepeer-review

58 Scopus citations


Rationale: The insulin-like growth factor-I (IGF-I) pathway is an important determinant of survival and proliferation in many cells. However, little is known about the role of the IGF-I pathway in lung injury. We previously showed elevated levels of IGF-I in bronchoal- veolar lavage fluid from patients with acute respiratory distress syndrome. Furthermore, immunodepletion of IGF from acute respiratory distress syndrome bronchoalveolar lavage increased fibro- blast apoptosis. Objectives: We examined the effect of blockade of type 1 IGF tyrosine kinase receptor (IGF-IR) in a murine model of bleomycin-induced lung injury and fibrosis. Methods-: Mice were treated with a monoclonal antibody against the IGF-I receptor (A12) or vehicle after intratracheal bleomycin instillation. Measurements and Main Results: Mice treated with A12 antibody had significantly improved survival after bleomycin injury compared with control mice. Both groups of mice had a similar degree of fibrosis on days 7 and 14, but by Day 28 the A12-treated group had significantly less fibrosis. Delayed treatment with A12 also resulted in decreased fibrosis. A12-treated mice had significantly decreased apoptotic cells on Day 28 compared with control mice. We confirmed that A12 treatment induced mouse lung fibroblast apoptosis in vitro. In addition, IGF-I increased lung fibroblast migration. The primary pathway activated by IGF-I in lung fibroblasts was the insulin receptor substrate-2/phosphatidylinositol 3-kinase/Akt axis. Conclusions: IGF-I regulated survival and migration of fibrogenic cells in the lung. Blockade of the IGF pathway increased fibroblast apoptosis and subsequent resolution of pulmonary fibrosis. Thus, IGF-IR may be a potential target for treatment of lung injury and fibrosis.

Original languageEnglish (US)
Pages (from-to)212-219
Number of pages8
JournalAmerican journal of respiratory and critical care medicine
Issue number3
StatePublished - Feb 1 2009


  • Insulin-like growth factor
  • Lung fibrosis
  • Lung injury

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'Insulin-Like growth factor-i receptor blockade improves outcome in mouse model of lung injury'. Together they form a unique fingerprint.

Cite this